Anra Pharmaceuticals Private Limited
About Anra Pharmaceuticals Private Limited
Data last updated:
Anra Pharmaceuticals Private Limited was a private limited company based in Vellaripatti, Tamil Nadu, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 1993.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1993PTC025515.
The company had an authorised share capital of ₹35 Lakh and a paid-up capital of ₹30 Lakh. It was led by directors Raja Ganesan (Managing Director) and Mamundi Raja.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Madurai Melur Road, Vellaripatti, Tamil Nadu, India – 625122.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.84 Cr, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹95.53 Lakh (net margin 5.7%) and EBITDA of ₹1.2 Cr (EBITDA margin 7.1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8 Lakh and satisfied charges of ₹63.73 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
Company details
Contact details
Anra Pharmaceuticals Private Limited's registered office is in Vellaripatti, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMadurai Melur Road, Vellaripatti, Tamil Nadu, India – 625122
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anra Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anra Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anra Pharmaceuticals Private Limited, buy the company report.
Financials of Anra Pharmaceuticals Private Limited
FY 2025 filings availableAnra Pharmaceuticals Private Limited reported revenue of ₹16.84 Cr (up 74% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 74% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anra Pharmaceuticals Private Limited
Anra Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mamundi Raja Also directs: Aura Formulation LLP, Anra Pharmaceuticals LLP | Director | 31 Dec 2017 | 8 Years 10 Months | As last reported |
| Raja Ganesan Also directs: Aura Formulation LLP, Anra Pharmaceuticals LLP | Managing Director | 29 Jul 1993 | 33 Years 3 Months | As last reported |
Peer comparison
Anra Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dollar Co Private Limited | ₹16.91 Cr (FY 2024) | -1.0% | Chennai, Tamil Nadu, India | |||
| Anuja Healthcare Limited | ₹16.86 Cr (FY 2025) | 3.0% | Chandigarh, India | |||
| Anra Pharmaceuticals Private Limitedthis company | ₹16.84 Cr (FY 2025) | ₹95.53 Lakh | 5.7% | 74.0% | 9 | Vellaripatti, Tamil Nadu, India |
| MVL Medisynth Private Limited | ₹16.78 Cr (FY 2024) | 1.0% | Solapur North, Maharashtra, India | |||
| Leiutis Pharmaceuticals Private Limited | ₹16.75 Cr (FY 2020) | 62.0% | Hyderabad, Telangana, India | |||
| Salius Pharma Private Limited | ₹16.74 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India |
To see the full peer comparison of Anra Pharmaceuticals Private Limited, buy the company report.
Auditor
Anra Pharmaceuticals Private Limited is audited by GANESH PRASAD for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GANESH PRASAD | FY 2022 | 000872S |
Shareholding
The shareholding of Anra Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Anra Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Mar 1999 | 90295402 | The Tamilnadu Industirial Investment Cor. Ltd. | ₹6.93 Lakh | Satisfied | |
| 26 Mar 1997 | 90292459 | The Tamilnadu Industrial Investments Corporation Ltd. | ₹1.7 Lakh | Satisfied | |
| 05 Jun 1996 | 90294411 | State Bank of India | ₹24 Lakh | Satisfied | |
| 23 Jun 1995 | 90292300 | The Tamilnadu Industrial Investments Corporation Ltd. | ₹31.1 Lakh | Satisfied |
To see the full charge records of Anra Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Anra Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Anra Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Company appeal | Filed by the company against an individual | Disposed |
To see the full case history of Anra Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Anra Pharmaceuticals Private Limited has a workforce of 9 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 9 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Anra Pharmaceuticals Private Limited, buy the company report.
GST
No GST registration is on our record for Anra Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Anra Pharmaceuticals Private Limited has 4 board changes on record since 1993: 2 appointments and 2 cessations. The latest: Mamundi Raja ceased to be Additional Director on 29 Sep 2018.
4 earlier events are in the company report.
Frequently asked questions
Anra Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Anra Pharmaceuticals was a private limited company based in Vellaripatti, Tamil Nadu, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 29 July 1993 and is registered under CIN U24231TN1993PTC025515. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Anra Pharmaceuticals is U24231TN1993PTC025515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anra Pharmaceuticals had 2 directors:
- Raja Ganesan - Managing Director
- Mamundi Raja - Director
Anra Pharmaceuticals was incorporated on 29 July 1993. It is registered with the Registrar of Companies, Chennai.
The registered office of Anra Pharmaceuticals is at Madurai Melur Road, Vellaripatti, Tamil Nadu, India – 625122.
The latest financial statements of Anra Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
Anra Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
The peers of Anra Pharmaceuticals by revenue are Dollar Co Private Limited, Anuja Healthcare Limited, MVL Medisynth Private Limited, Leiutis Pharmaceuticals Private Limited, Salius Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anra Pharmaceuticals has 1 court case on record: 1 filed by the company.
Mamundi Raja ceased to be Additional Director on 29 Sep 2018. Mamundi Raja was appointed as Director on 31 Dec 2017. Narayanan Ganesan ceased to be Director on 31 Dec 2017. Anra Pharmaceuticals has 4 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
